GPX4 and urinary bladder carcinoma: Additionally, in bladder cancer, although GPX4 acts to inhibit ferroptosis, autophagy facilitates the degradation of GPX4, augmenting the efficacy of Fin56 in stimulating ferroptosis (Sun Y. et al., 2021).